Intravenous infusion of engineered megakaryocytes to produce oncolytic platelets in vivo for enhanced cancer immunotherapy

Journal:
Proceedings of the National Academy of Sciences of the United States of America
Published:
DOI:
10.1073/pnas.2419694123
Affiliations:
12
Authors:
14
Go to article
Institutions Authors Share
State Key Laboratory of Advanced Drug Delivery System, China
8.000000
 0.57
State Key Laboratory of Vaccines for Infectious Diseases, XMU, China
1.333333
 0.10
Jinhua Institute of Zhejiang University, China
1.166667
 0.08
Blood Center of Zhejiang Province, China
1.000000
 0.07
The Second Affiliated Hospital, Zhejiang University School of Medicine, China
0.750000
 0.05
Zhejiang University (ZJU), China
0.583333
 0.04
Zhejiang University Medical Center, China
0.416667
 0.03
Sir Run Run Shaw Hospital (SRRSH), Zhejiang University School of Medicine, China
0.416667
 0.03
The First Affiliated Hospital of Xiamen University, China
0.333333
 0.02
Interested in Oncology and Carcinogenesis?